Ulrich Granzer

Chief Executive Officer at

Granzer Regulatory Consulting & Services

65 year

75 connections

Health Technology

Consumer Services

Finance

Profile

Ulrich Granzer is the founder of Granzer Regulatory Consulting & Services, which was founded in 2002.
He is currently the Director at Cardior Pharmaceuticals GmbH, a Venture Partner at Wellington Partners GmbH since 2004, and a Member-Supervisory Board at APEIRON Biologics AG since 2021.
Dr. Granzer previously served as the Chairman-Supervisory Board at Biofrontera AG from 2016 to 2021.
He also held positions as Director of Regulatory Affairs at Bayer AG, GSK Plc, and Knoll AG.
Additionally, he was a Director-Supervisory Board at Immatics Biotechnologies GmbH from 2009 to 2012 and Head of Regulatory Affairs at Bayer Pharma AG.
Dr. Granzer holds a doctorate degree from Eberhard Karls Universität Tübingen and a graduate degree from Philipps University of Marburg.

Ulrich Granzer active positions

Companies	Position	Start
Granzer Regulatory Consulting & Services	Chief Executive Officer	2001-12-31
Wellington Partners GmbH Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor.	Private Equity Investor	2003-12-31
Cardior Pharmaceuticals GmbH Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts	Director/Board Member	-
APEIRON Biologics AG APEIRON Biologics AG BiotechnologyHealth Technology Develops therapies for cancer immunotherapy and respiratory diseases	Director/Board Member	2021-06-20

All active positions of Ulrich Granzer

Former positions of Ulrich Granzer

Companies	Position	End
BIOFRONTERA AG	Chairman	2021-12-13
BAYER AG	General Counsel	-
Knoll AG Knoll AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	General Counsel	-
GSK PLC	General Counsel	-
Bayer Pharma AG Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	General Counsel	-

See the detail of Ulrich Granzer's experience

Training of Ulrich Granzer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ulrich Granzer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Bayer AG Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Knoll AG Knoll AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology
Wellington Partners GmbH Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor.	Finance
Biofrontera AG Biofrontera AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops and distributes dermatological products	Health Technology
Immatics Biotechnologies GmbH Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer	Health Technology
Eberhard Karls Universität Tübingen Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Philipps University of Marburg Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bayer Pharma AG Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
APEIRON Biologics AG APEIRON Biologics AG BiotechnologyHealth Technology Develops therapies for cancer immunotherapy and respiratory diseases	Health Technology
Granzer Regulatory Consulting & Services
Cardior Pharmaceuticals GmbH Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts	Health Technology